Clinical Trials Logo

Clinical Trial Summary

Mitral valve reconstruction via minimal invasive antero- lateral thoracotomy is done in cardioplegia with a cardioplegic solution, either HTK-Bretschneider (Custidiol®) (a crystalloid intracellular solution) or St. Thomas (a crystalloid extracellular solution).

This study investigates HTK-Bretschneider versus St. Thomas cardioplegic solution regarding peri- and postoperative outcome, especially for cardiac biomarkers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03818113
Study type Observational
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase
Start date April 1, 2019
Completion date August 30, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT03798015 - Neurologic Outcome After Mitral Valve Surgery